Publicaciones en colaboración con investigadores/as de Pitié-Salpêtrière Hospital (10)

2024

  1. Psychopharmacology in children and adolescents: unmet needs and opportunities

    The Lancet Psychiatry, Vol. 11, Núm. 2, pp. 143-154

2023

  1. Digital mental health: challenges and next steps

    BMJ mental health, Vol. 26, Núm. 1

  2. Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033

    Neuro-oncology, Vol. 25, Núm. 8, pp. 1443-1449

  3. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

  4. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications

    Neuroscience and Biobehavioral Reviews, Vol. 149

2022

  1. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel

    Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1528-1553

2020

  1. What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons

    Neurobiology of Aging, Vol. 85, pp. 58-73

2019

  1. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

    Nature Communications, Vol. 10, Núm. 1

2011

  1. De novo RYR1 heterozygous mutation (I4898T) causing lethal core-rod myopathy in twins

    European Journal of Medical Genetics, Vol. 54, Núm. 1, pp. 29-33